| 中文名称 | L-高胱氨酸 |
| 英文名称 | L-Homocystine |
| CAS号 | 626-72-2 |
| 分子式 | C8H16N2O4S2 |
| 分子量 | 268.35 |
| EINECS号 | 210-962-5 |
| 熔点 | 281-284 °C (dec.)(lit.) |
| 比旋光度 | 77 º (c=1% in 1N HCl) |
| 沸点 | 507.6±50.0 °C(Predicted) |
| 密度 | 1.443±0.06 g/cm3(Predicted) |
| 溶解度 | H2O:5 mg/mL(18.63 mM;超声并用 H2O 将 pH 调节至 3)DMSO:1 mg/mL(3.73 mM;超声并用 HCl 将 pH 调节至 5) |
| 形态 | 粉末 |
| 酸度系数(pKa) | 1.90±0.10(Predicted) |
| 颜色 | 米白色至浅黄色 |
| BRN | 1728583 |
| 安全说明 | 22-24/25 |
| WGK Germany | 3 |
| 海关编码 | 29309090 |
|
Human Endogenous Metabolite
|
A single or multiple doses of L-Homocystine administered to mice during organogenesis can aggravate the developmental disturbances caused by a single dose of VPA administered on GD 8. Whereas, VPA lowers significantly plasma FA and vitamin B12 concentrations, it has no direct impact on the homocysteine concentrations. Therefore, it is proposed that high levels of homocysteine disturb the FA, vitamin B12, and possibly methionine metabolism thus providing a favorable situation for VPA to interfere with the development of susceptible embryos.